Since the initial posting of the Open Letter to Parents and Pediatricians Regarding COVID Vaccines (https://notesfromthesocialclinic.org/an-open-letter-to-parents-and-pediatricians-2/), new scientific information has emerged that has added strength, further detail, and further clarity to the concerns and understandings explained in the Open Letter. In particular, Dr. Geert Vanden Bossche has authored two new illuminating articles, entitled The Immunologic Rationale Against C-19 Vaccination of Children and Predictions on the Evolution of the COVID-19 Pandemic. Here are links to those two articles:
To share the above-mentioned additional information with parents and pediatricians, we have co-authored this Open Letter Part II: A Review and Update.
In Part II we have provided 37 references. In addition, the reader is referred to the 1078 references in the original Open Letter and to the many other references in Dr. Vanden Bossche’s two articles.
The reader is also referred to the following video-interviews, regarding the Open Letter: Video-interview (Dr. Philip McMillan and Dr. Rennebohm): https://www.youtube.com/watch?v=uDRVq9NKrJQ&t=981s
Video-conversation between Dr. Vanden Bossche, Dr. McMillan, and Dr. Rennebohm: https://philipmcmillan.substack.com/p/first-recorded-discussion-between?s=w
Further information about COVID may be found on the following websites:
Dr. Vanden Bossche’s website: voiceforscienceandsolidarity.org
Dr. Rennebohm’s website: notesfromthesocialclinic.org
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.